首页> 外文期刊>BMC Pulmonary Medicine >Risk factors of postoperative pulmonary complications in patients with asthma and COPD
【24h】

Risk factors of postoperative pulmonary complications in patients with asthma and COPD

机译:哮喘和COPD患者术后肺部并发症的危险因素

获取原文
           

摘要

Postoperative pulmonary complications (PPC) in patients with pulmonary diseases remain to be resolved clinical issue. However, most evidence regarding PPC has been established more than 10?years ago. Therefore, it is necessary to evaluate perioperative management using new inhalant drugs in patients with obstructive pulmonary diseases. April 2014 through March 2015, 346 adult patients with pulmonary diseases (257 asthma, 89 chronic obstructive pulmonary disease (COPD)) underwent non-pulmonary surgery except cataract surgery in our university hospital. To analyze the risk factors for PPC, we retrospectively evaluated physiological backgrounds, surgical factors and perioperative specific treatment for asthma and COPD. Finally, 29 patients with pulmonary diseases (22 asthma, 7 COPD) had PPC. In patients with asthma, smoking index (≥ 20 pack-years), peripheral blood eosinophil count (≥ 200/mm3) and severity (Global INitiative for Asthma(GINA) STEP?≥?3) were significantly associated with PPC in the multivariate logistic regression analysis [odds ratio (95% confidence interval)?=?5.4(1.4–20.8), 0.31 (0.11–0.84) and 3.2 (1.04–9.9), respectively]. In patients with COPD, age, introducing treatment for COPD, upper abdominal surgery and operation time (≥ 5?h) were significantly associated with PPC [1.18 (1.00–1.40), 0.09 (0.01–0.81), 21.2 (1.3–349) and 9.5 (1.2–77.4), respectively]. History of smoking or severe asthma is a risk factor of PPC in patients with asthma, and age, upper abdominal surgery, or long operation time is a risk factor of PPC in patients with COPD. Adequate inhaled corticosteroids treatment in patients with eosinophilic asthma and introducing treatment for COPD in patients with COPD could reduce PPCs.
机译:肺部疾病患者的术后肺部并发症(PPC)仍有待解决。但是,大多数有关PPC的证据已经建立了10多年前。因此,有必要评估阻塞性肺疾病患者使用新的吸入药物的围手术期管理。 2014年4月至2015年3月,我校医院除白内障手术外,其余346例成年肺部疾病患者(257例哮喘,89例慢性阻塞性肺疾病(COPD))接受了非肺部手术。为了分析PPC的危险因素,我们回顾性评估了哮喘和COPD的生理背景,手术因素和围手术期特异性治疗。最后,有29例肺部疾病(22例哮喘,7例COPD)患有PPC。哮喘患者的吸烟指数(≥20包年),外周血嗜酸性粒细胞计数(≥200 / mm3)和严重程度(全球哮喘起始剂量(GINA)STEP≥3)与PPC显着相关回归分析[赔率(95%置信区间)分别为?5.4(1.4-20.8),0.31(0.11-0.84)和3.2(1.04-9.9)]。在患有COPD的患者中,年龄,采用COPD的治疗方法,上腹部手术和手术时间(≥5?h)与PPC显着相关[1.18(1.00–1.40),0.09(0.01–0.81),21.2(1.3–349)和9.5(1.2–77.4),分别]。吸烟史或严重哮喘是哮喘患者中PPC的危险因素,而年龄,上腹部手术或长时间手术是COPD患者中PPC的危险因素。嗜酸性粒细胞性哮喘患者充分吸入皮质类固醇激素治疗,而COPD患者引入COPD治疗可减少PPC。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号